Nu Skin Enterprises (NYSE:NUS – Free Report) had its target price cut by DA Davidson from $12.50 to $11.00 in a research report sent to investors on Monday, Benzinga reports. They currently have a neutral rating on the stock. DA Davidson also issued estimates for Nu Skin Enterprises’ Q3 2024 earnings at $0.19 EPS, FY2024 earnings at $0.75 EPS and FY2025 earnings at $0.90 EPS.
Separately, Citigroup dropped their target price on Nu Skin Enterprises from $14.00 to $11.50 and set a neutral rating on the stock in a research note on Friday, August 9th. Four research analysts have rated the stock with a hold rating, According to data from MarketBeat, Nu Skin Enterprises has a consensus rating of Hold and an average price target of $16.50.
Read Our Latest Analysis on Nu Skin Enterprises
Nu Skin Enterprises Stock Up 2.8 %
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 9.28% and a negative net margin of 0.17%. The firm had revenue of $439.10 million for the quarter, compared to the consensus estimate of $431.87 million. During the same period in the previous year, the business earned $0.54 EPS. The firm’s revenue for the quarter was down 12.2% on a year-over-year basis. On average, research analysts expect that Nu Skin Enterprises will post 1.1 earnings per share for the current fiscal year.
Nu Skin Enterprises Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 11th. Shareholders of record on Friday, August 30th will be paid a dividend of $0.06 per share. The ex-dividend date is Friday, August 30th. This represents a $0.24 annualized dividend and a yield of 2.43%. Nu Skin Enterprises’s payout ratio is presently -400.00%.
Insider Buying and Selling at Nu Skin Enterprises
In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 2,000 shares of the business’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $13.33, for a total transaction of $26,660.00. Following the sale, the director now owns 23,225 shares in the company, valued at approximately $309,589.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 1.70% of the company’s stock.
Hedge Funds Weigh In On Nu Skin Enterprises
Several institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of Nu Skin Enterprises by 4.4% in the 1st quarter. Vanguard Group Inc. now owns 6,489,580 shares of the company’s stock valued at $89,751,000 after buying an additional 274,309 shares during the period. Pacer Advisors Inc. acquired a new position in Nu Skin Enterprises in the 2nd quarter worth about $25,230,000. Federated Hermes Inc. raised its holdings in Nu Skin Enterprises by 111.8% in the 2nd quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company’s stock worth $13,950,000 after purchasing an additional 698,722 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Nu Skin Enterprises by 17.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock worth $22,482,000 after purchasing an additional 173,193 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in Nu Skin Enterprises by 5.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 901,098 shares of the company’s stock worth $9,498,000 after purchasing an additional 43,935 shares during the period. Institutional investors and hedge funds own 82.84% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Featured Articles
- Five stocks we like better than Nu Skin Enterprises
- What Are the U.K. Market Holidays? How to Invest and Trade
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Jeff Brown’s Exegesis AI Stock Picks
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.